Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
about
The clinical importance of conventional and quantitative liver function tests in liver transplantation.MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study.Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver functionEven 'safe' medications need to be administered with care.Long-term follow up of chronic hepatitis C patients after alpha-interferon treatment: a functional study.
P2860
Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
@en
Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
@nl
type
label
Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
@en
Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
@nl
prefLabel
Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
@en
Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
@nl
P2093
P1476
Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
@en
P2093
A J Sanyal
E B Thompson
M L Shiffman
V A Luketic
P304
P356
10.1097/00007691-199608000-00010
P577
1996-08-01T00:00:00Z